Health
Researchers evaluate frequency of SARS-CoV-2 in hematology/oncology settings – News-Medical.Net
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency…
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.
The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces…
-
General18 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General9 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General16 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
General22 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat